Infinity Pharma Stock Price (NASDAQ:INFI)

Add to My Stocks
$1.84 $0.01 (0.54%) INFI stock closing price Feb 21, 2018 (Closing)
Prev Close* : $1.85
Market Cap:
$94.32M
Day Low: $1.81
52 Week Low: $0.93
Open: $1.86
Volume: -
Day High: $1.94
52 Week High: $3.84
Dividend:
0.00

Latest Stock Market News

Latest Articles

Infinity Pharma News - From Partners

Should You Get Rid of Patheon (PTHN) Now?   by Zacks on Mar 29, 2017

INFI Stockcharts

View INFI PE ratio, PS ratio stocks charts and compare with peers.
INFI Chart
Note: Compare Infinity Pharma stock price history with the index and industry peers.

Infinity Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
15.53
PB ratio (
price to book ratio
)
1.26

Infinity Pharma Returns

ROE
(return on equity)
-78%

Infinity Pharma Financial Ratios

Asset Turnover
0.31
Receivables Turnover
-
Debt to Equity
0.11
Dividend Yield
0%

INFI Industry Peers

Company Price Change (%)
Affirmed (AFMD)2.150.07 (3.37%)
Medicure (MCUJF)5.840 (0%)
Seattle Genetics (SGEN)54.110.05 (0.09%)
Bristol-myers Squibb (BMY)66.530.82 (1.22%)
Johnson & Johnson (JNJ)130.872.28 (1.71%)
Arqule (ARQL)1.670.02 (1.21%)
Gilead Sciences (GILD)80.690.25 (0.31%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Tetraphase Pharmaceuticals (TTPH)2.20.12 (5.77%)
Akebia Therapeutics (AKBA)14.310.69 (5.07%)
ChemoCentryx (CCXI)9.70.4 (4.3%)
Flexion Therapeutics (FLXN)24.581 (4.24%)
ImmunoGen (IMGN)11.680.43 (3.82%)
PTC Therapeutics (PTCT)25.010.87 (3.6%)
Nektar Therapeutics (NKTR)86.453 (3.59%)
Top gainers from Medical-Drugs industry
* As of Feb 21, 2018
CompanyPriceChange (%)
Adamis Pharma (ADMP)2.820.31 (9.92%)
United Therapeutics (UTHR)122.1712.79 (9.48%)
Portola Pharma (PTLA)44.913.31 (6.86%)
Neptune Tech. & Bio. (NEPT)2.850.14 (4.68%)
TherapeuticsMD (TXMD)5.110.2 (3.77%)
Pacira Pharma (PCRX)30.151.1 (3.52%)
MediWound (MDWD)4.350.15 (3.33%)
Top losers from Medical-Drugs industry
* As of Feb 21, 2018

Infinity Pharmaceuticals Inc. Stock News - Partner Headlines

Value Investing in BioPharma   on Nov 18, 2015

Infinity Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues18.72M109.06M164.99M-47.11M
Net Income-30.1M-128.37M-17.41M-126.78M-53.96M
Total Operating Expense49.62M236.16M172.91M127.67M99.92M
View Infinity Pharma income statement
balance sheet20162015201420132012
Total Assets125.65M288.82M369.14M230.71M335.66M
Total Liabilities43.2M190.26M159.67M29.43M25.45M
Shareholders Equity82.45M98.55M209.47M201.27M310.2M
View Infinity Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-29.22M26.97M109.57M-3.71M-39.39M
Net Cash from (used by) Operating Activities-154.35M-83.65M117.71M-113.9M-80.13M
Increase (Decrease) in Prop Plant And Equipment1.47M-6.42M-1.36M-1.75M-1.3M
View Infinity Pharma cash flow statement

Infinity Pharma Stock Message Board

An investor needs to spend $1.84 to buy INFI stock, as the closing Infinity Pharma stock price is $1.84. Stock price or share price can be used to find the total market value of a company. Infinity Pharma market cap stands at $94.32M as of Feb 21, 2018. Infinity Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Infinity Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 318,009 INFI shares were traded yesterday, and Infinity Pharma stock chart shows that the INFI stock quote hit a day high of $1.94 and day low of $1.81. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Infinity Pharma stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Infinity Pharma stock price history.